3. Definition
• Acne vulgaris is a chronic disorder of the pilosebaceous apparatus caused by abnormal
desquamation of follicular epithelium leading to obstruction of the pilosebaceous
canal, inflammation, and subsequent formation of comedones, papules,
pustules, nodules, and scarring. Based on their appearance, the acne lesions can
be divided into inflammatory (presence of papules, pustules, and nodules) and
noninflammatory (open and closed comedones). For inflammatory acne, lesions
can be classified as papulopustular, nodular, or both. The American Academy of
Dermatology classification scheme for acne denotes the following three levels:
1. Mild acne: characterized by the presence of comedones (noninflammatory lesions),
few papules and pustules (generally <10), but no nodules.
2. Moderate acne: presence of several to many papules and pustules (10–40) along with
comedones (10–40). The presence of more than 40 papules and pustules along with
larger, deeper, nodular, inflamed lesions (up to 5) denotes moderately severe acne.
3. Severe acne: presence of numerous or extensive papules and pustules as well as
many nodular lesions.
4. • Acne is a follicular disease, with the principal abnormality being comedo formation.
• Overactivity of the sebaceous glands and blockage in the ducts result in acne vulgaris.
The obstruction leads to the formation of comedones, which can become inflamed
because of overgrowth of Propionibacterium acnes. The condition can be exacerbated
by environmental factors (hot, humid, tropical climate), medications (e.g., iodine in
cough mixtures, hair greases), and industrial exposure to halogenated hydrocarbons.
Mechanical or frictional forces can aggravate existing acne (e.g., excessive washing by
some patients to help rid them of their blackheads or oiliness).
5. Clinical Manifestation(s)
• Various stages of development and severity may be
present concomitantly.
• Common distribution of acne is on the face, back,
and upper chest
6. Physical Examination
• Open comedones (blackheads), closed
comedones(whiteheads)
• Inflammatory papules, pustules and ectatic pores
• Inflammatory and noninflammatory acneiform cysts
• Greasiness (oily skin)
• Presence of scars from prior acne lesions
7. Diagnostic Tests
• Laboratory evaluation is generally not helpful.
• Patients who are candidates for therapy with isotretinoin (Accutane)
should have baseline liver enzymes, cholesterol, and triglycerides
checked because this medication may result in elevation of lipids and
liver enzyme
• Negative urine or serum pregnancy test must be obtained in female
patients one month prior to, upon initiation of, and monthly when
taking isotretinoin.
• In female patients, if hyperandrogenism is suspected, levels of
dehydroepiandrosterone sulfate (DHEAS), testosterone (total and
free), and Androstenedione should be measured. Generally, for women
with regular menstrual cycles, serum androgen measurements are not
necessary.
9. TREATMENT
First Line
• Treatment generally varies with the type of lesions (comedones, papules, pustules,
cystic lesions) and the severity of acne.
• Comedones (noninflammatory acne) can be treated with retinoids or retinoid
analogs. Topical retinoids are comedolytic and normalize follicular keratinization.
Commonly available agents are adapalene (0.1% gel or cream, applied once
or twice daily), tazarotene (0.1% cream or gel applied daily), and tretinoin (0.1%,
0.5%, or 0.025% cream or gel applied once nightly). Tretinoin is inactivated by
UV light and oxidized by benzoyl peroxide; therefore, it should only be applied at
night and not used concomitantly with benzoyl peroxide. Tretinoin is pregnancy
category C; tazarotene is pregnancy category X.
• Salicylic acid preparations (e.g., 2% wash) have keratolytic and antiinflammatory
properties and are also useful in the treatment of comedones. Large open comedones
(blackheads) may be expressed.
10. First Line continu……
• Benzoyl peroxide gel (2.5% or 5%) may be added if the comedones become inflamed or
form pustules. The most common adverse effects are dryness, erythema, and peeling.
• Topical antibiotics (erythromycin, clindamycin lotions or pads) can also be used in
patients with significant inflammation. They reduce P. acnes in the pilosebaceous
follicle and have some antiinflammatory effects. Combination products containing
5% benzoyl peroxide with topical antibiotics (3% erythromycin or 1% clindamycin)
are highly effective in patients who have a mixture of comedonal and inflammatory
acne lesions. Fixed-dose combinations of clindamycin phosphate 1.2% and tretinoin
0.025% are also available and are more effective than either product used alone; however,
they are much more expensive than the individual generic components.
• Pustular acne can be treated with tretinoin and benzoyl peroxide gel applied on
alternate
evenings; drying agents (sulfa containing products) are also effective when
used in combination with benzoyl peroxide.
• Azelaic acid, a bacteriostatic dicarboxylic acid, is used to normalize keratinization
and reduce inflammation. It may be preferred in pregnancy (pregnancy category B).
11. Second Line
• Oral antibiotics (doxycycline 50–100 mg QD-BID or minocycline 50–100 mg QDBID)
are effective in patients with moderate to severe pustular acne. Erythromycin
may also be used but has high rates of bacterial resistance. It is pregnancy category B
• Patients with nodular cystic acne should be treated with systemic agents, including
antibiotics (erythromycin, tetracycline, doxycycline, minocycline), isotretinoin,
and/or oral contraceptives. Periodic intralesional triamcinolone injections are also
effective for individual painful lesions. The possibility of endocrinopathy should be
considered in patients responding poorly to therapy.
• Oral contraceptives reduce androgen levels and therefore sebum production. They
represent a useful adjunctive therapy for some types of acne in women and adolescent
girls but are not considered first-line therapy and should not be used as
monotherapy for acne vulgaris. Commonly used agents are norgestimate/ethinyl
estradiol and drospirenone/ethinyl estradiol.
• Spironolactone 100 to 200 mg/day can be administered to women only and has
been shown to be particularly effective for adult-onset or “beard distribution”
acne.
• Blue light can be used for treatment of moderate inflammatory acne vulgaris. Light
in the violet/blue range can cause bacterial death by a photoreaction in which porphyrins
react with oxygen to generate reactive oxygen species, which damage the
cell membranes of P. acnes. Treatment usually consists of 15-minutes of exposure
twice weekly for 4 weeks.
12. Third Line
• Isotretinoin is indicated for acne resistant to antibiotic
therapy, severe acne, and scarring acne. Dosage is 0.5 to 1
mg/kg/day, and duration of therapy is generally
20 weeks for a cumulative dose 120 to 150 mg/kg. Before
using this medication, patients should undergo baseline
laboratory evaluation as described previously.
Isotretinoin is absolutely contraindicated during
pregnancy because of its teratogenicity.
Patients, providers, pharmacies, and distributors of the
drug must register in the iPLEDGE program prior to
initiation of therap.